CompanyGraph
Lifetech Scientific Corporation
1302 · HKEX · China
Price data from its 81X listing on XSTU, quoted in EUR
lifetechmed.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleLevered free cash flow is $151.29M, above the global median of $16.24M
- PositionGross margin is 80.9%, higher than 95% of its Medical Devices peers (median 59.2%)
- Interpretations7 currently firing — 7
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.45BHKD1.08B · vs all stocks (USD)
Trailing P/E
35.38xvs Medical Devices peers
Revenue (TTM)
1.59BCNY203.23M · vs all stocks (USD)
Profit Margin
10.79%vs Medical Devices peers
Beta
0.3330xvs all stocks
52-Week Change
-36.79%vs all stocks
Market Capitalization
8.45BHKD1.08B · vs all stocks (USD)
Enterprise Value
6.17BHKD787.07M · vs all stocks (USD)
Trailing P/E
35.38xvs Medical Devices peers
Price to Sales (TTM)
4.55xvs Medical Devices peers
Price to Book (MRQ)
1.60xvs Medical Devices peers
Enterprise to Revenue
3.87xvs Medical Devices peers
Enterprise to EBITDA
18.18xvs Medical Devices peers
Gross Margin
80.91%vs Medical Devices peers
Profit Margin
10.79%vs Medical Devices peers
Operating Margin
23.76%vs Medical Devices peers
Return on Assets (TTM)
2.46%vs Medical Devices peers
Return on Equity (TTM)
3.23%vs Medical Devices peers
Revenue (TTM)
1.59BCNY203.23M · vs all stocks (USD)
Revenue per Share (TTM)
0.3130CNYUpdated Aug 19, 2026Quarterly Revenue Growth
6.50%vs Medical Devices peers
Gross Profit (TTM)
1.19BCNY151.21M · vs all stocks (USD)
EBITDA (TTM)
41.57MCNY5.30M · vs all stocks (USD)
Net Income (TTM)
172.04MCNY21.93M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
451.10%vs Medical Devices peers
Operating Cash Flow (TTM)
639.24MCNY81.50M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.19BCNY151.29M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00HKDUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
-37.54MCNYFY2025 · Dec 31, 2025Revenue
1.37BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
350.67MCNYFY2025 · Dec 31, 2025Gross Profit
1.02BCNYFY2025 · Dec 31, 2025Operating Income
175.88MCNY26.08M · vs all stocks (USD)
Pre-tax Income
191.45MCNYFY2025 · Dec 31, 2025Income Tax Expense
79.08MCNYFY2025 · Dec 31, 2025Net Income
112.38MCNYFY2025 · Dec 31, 2025EBIT
191.66MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
310.07MCNYFY2025 · Dec 31, 2025Research & Development
242.66MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
607.13MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
25.46MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
210.00KCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
35.45MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
511.62MCNYFY2025 · Dec 31, 2025Free Cash Flow
445.17MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
719.32MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
191.45MCNYFY2025 · Dec 31, 2025Stock-based Compensation
223.29MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-17.81MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
18.04MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
96.65MCNYFY2025 · Dec 31, 2025Capital Expenditures
-66.45MCNYFY2025 · Dec 31, 2025Net Intangibles (CF)
-81.78MCNYFY2025 · Dec 31, 2025Net Acquisitions
-30.53MCNYFY2025 · Dec 31, 2025Purchase of Investments
-530.78MCNYFY2025 · Dec 31, 2025Sale of Investments
596.13MCNYFY2025 · Dec 31, 2025Other Investing Activity
-39.43MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-71.06MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00CNYFY2025 · Dec 31, 2025Long-term Debt Payments
0.00CNYFY2025 · Dec 31, 2025Other Financing Charges
24.00MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-365.05MCNYFY2025 · Dec 31, 2025Shares Outstanding
4.40BSharesUpdated Aug 19, 2026Float Shares
3.58BSharesUpdated Aug 19, 2026% Held by Insiders
22.45%vs all stocks
% Held by Institutions
7.18%vs all stocks
Total Cash (MRQ)
1.34BCNY170.64M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2480CNYUpdated Aug 19, 2026Total Debt (MRQ)
9.35MCNY1.19M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0023xvs Medical Devices peers
Current Ratio (MRQ)
1.57xvs Medical Devices peers
Book Value per Share (MRQ)
0.8821CNYUpdated Aug 19, 2026Total Assets
5.01BCNY743.34M · vs all stocks (USD)
Total Current Assets
2.33BCNYFY2025 · Dec 31, 2025Total Liabilities
1.54BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.69BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
57.91MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.48BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
719.32MCNYFY2025 · Dec 31, 2025Other Short-term Investments
430.78MCNYFY2025 · Dec 31, 2025Accounts Receivable
161.80MCNYFY2025 · Dec 31, 2025Inventory
444.90MCNYFY2025 · Dec 31, 2025Accounts Payable
84.70MCNYFY2025 · Dec 31, 2025Short-term Debt
3.76MCNYFY2025 · Dec 31, 2025Long-term Debt
4.28MCNYFY2025 · Dec 31, 2025Common Stock (Book)
37.00KCNYFY2025 · Dec 31, 2025Retained Earnings
2.02BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.48BCNY515.36M · vs all stocks (USD)
52-Week Low
1.30HKDUpdated Aug 19, 202652-Week High
2.44HKDUpdated Aug 19, 202652-Week Change
-36.79%vs all stocks
Beta
0.3330xvs all stocks
50-Day MA
1.46HKDUpdated Aug 19, 2026200-Day MA
1.71HKDUpdated Aug 19, 2026Avg 10-Day Volume
18.14MSharesUpdated Aug 19, 2026Avg 30-Day Volume
20.26MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.0400CNYUpdated Aug 19, 20267 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 80.9%, higher than 95% of its Medical Devices peers (median 59.2%)Significant
Gross margin: 0.81Industry median: 0.59Industry P95: 0.80Peers compared: 59.00
Financial Health
Altman Z-Score 3.99: safe zoneNotable
Altman Z-Score: 3.99
High earnings qualityNotable
Earnings Quality Score: 0.55
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Levered free cash flow is $151.29M, above the global median of $16.24MNotable
Levered free cash flow (USD): 151,292,746.729Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Kanion Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Dezhan Health Care Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Changchun BCHT Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eis Eczacıbaşı İlaç ve Sanayi A.Ş.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Anhui Wanbang Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cullinan Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Akums Drugs & Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kuros Biosciences AG
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Blue Jet Healthcare Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Alto Neuroscience Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Jiangsu Rutong Petro-Machinery Co., Ltd.
7 interpretationsHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksCash-Flow Ratios ElevatedDrawdown With FCF And Cash BackingClose Below 40W SMA With ProfitabilityPrice Below Mean With Profitability And EquityCash Backing With OCF Coverage And Cash Near Total Debt
Indian Railway Catering and Tourism Corporation Ltd.
5 interpretationsCash Backing With Revenue And Income StreaksCash-Flow Ratios ElevatedDrawdown With FCF And Cash BackingClose Below 40W SMA With ProfitabilityCash Backing With OCF Coverage And Cash Near Total Debt
Zozo, Inc.
5 interpretationsHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksCash-Flow Ratios ElevatedDrawdown With FCF And Cash BackingCash Backing With OCF Coverage And Cash Near Total Debt